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 Apart from their primary functions in innate immunity and phagocytosis, macrophages 
are critical regulators of inflammation through their ability to adopt polarization states, a 
spectrum of phenotypes in which macrophages change their morphology and produce large 
amounts of pro/anti-inflammatory cytokines and biomolecules. Dysregulated macrophage 
polarization has been implicated in numerous chronic inflammatory diseases. However, as a 
result of the tightly-regulated nature of macrophage polarization, it is difficult to design 
immunomodulatory strategies for modulating macrophage polarization without a robust 
understanding of the temporal dynamics involved. As a result, there is a need for a deeper 
understanding of polarization dynamics that can be used in conjunction with computational 
modeling to develop better immunomodulatory strategies. In this thesis, RAW 264.7 murine 
macrophages are subject to a number of different stimulation strategies in order to temporally 
characterize how these cells translate inputs (such as pro-inflammatory cytokines and 
biomolecules) into a key marker of pro-inflammatory polarization output (iNOS expression over 
time). Specifically, I measured iNOS expression primarily through immunocytochemistry 
performed in either 96-well microwell plates or in PDMS microfluidic devices for three-
dimensional (3D) culture experiments. Performing polarization experiments in microfluidic 
devices revealed that 3D culture environments exhibit differences in polarization dynamics. In 
particular, I found that the M1 response to lipopolysaccharide (LPS) stimulation is always 
transient regardless of whether macrophages are re-stimulated with fresh LPS-containing 
medium. Subsequently, I investigated re-stimulating with an M1 cytokine that activates different 
pathways than LPS to upregulate pro-inflammatory genes, referred to in this thesis as an 
orthogonal stimulus. Interestingly, further re-stimulation with an orthogonal stimulus, which 
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upregulates iNOS through a separate pathway, such as interferon-γ, can extend M1 polarization 
and reach greater levels of iNOS expression than any single stimulus alone, in an order and dose-
dependent fashion. I also showed that culturing macrophages in a three-dimensional environment 
within microfluidic devices delays their response to LPS but exhibits the same critical maximum 
of iNOS expression, suggesting a potential role for the extracellular matrix in regulating 
polarization dynamics. This thesis contributes novel findings to our understanding of 
macrophage polarization and proposes new avenues of investigation into the dynamics of other 
important cytokines in both 2D and 3D culture environments. These results may inform the 
development of novel models for understanding the temporal dynamics of macrophage 
polarization and direct further work into modulating polarization states for the treatment of 




Macrophages are a subset of white blood cells which serve as one of the first lines of 
defense in the immune system. Their primary function is to combat infection by engulfing 
pathogens through a process known as phagocytosis1. Over the course of the host’s response, 
macrophages polarize to different states, where they promote or resolve inflammation by 
secreting signaling molecules, i.e. cytokines. Macrophages first polarize towards a pro-
inflammatory (M1) state, marked by increased inducible nitric oxide synthase (iNOS) 
expression. M1 polarized macrophages induce inflammation in the local tissue environment and 
are important for anti-microbial responses during infections. Then, to resolve inflammation, 
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macrophages enter an M2 state, marked by Arginase-1, in which they upregulate proteins 
involved in tissue repair and remodeling2.  
 Regulation of macrophage polarization is a promising area of research for diseases 
characterized by chronic inflammation, such as Alzheimer’s disease3 and diabetes4. M2 
macrophages are also known to play a role in cancer biology in the form of tumor-associated 
macrophages, which locally attenuate immune response within the tumor microenvironment5. 
The translational relevance of modulating macrophage polarization to a diverse range of 
common and serious health issues suggests that it may be an attractive target for therapy. 
 However, the tightly-regulated and temporal nature of macrophage polarization poses 
challenges for developing methods to modulate their phenotype in a controlled-manner and 
without interfering with other important functions of the immune system. While the cytokines 
and biomolecules responsible for macrophage polarization have been well characterized, the 
dynamics of how these stimuli contribute to promoting chronic inflammation has been mostly 
unexplored.  
 This thesis investigates how inputs to macrophage polarization, such as cytokines and 
biomolecules, give rise to outputs in the form of polarization outputs. I have characterized 
macrophage polarization responses across a diverse range of stimulation strategies, as well as 
illuminating new differences in polarization dynamics across two-dimensional and three-
dimensional culture platforms. Likewise, my work has demonstrated that macrophage 
polarization exhibits hysteretic dynamics, in which prior states of macrophage polarization affect 
the future dynamics of polarization. This has substantial implications for modeling macrophage 
polarization trajectories because it demonstrates that models for macrophage polarization must 
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take prior states of the system in consideration to fully recapitulate the dynamics.  
 
LITERATURE REVIEW: 
Macrophages were first identified by Russian zoologist Élie Metchnikoff in 1882 due to 
their unique ability to perform phagocytosis1. However, over the past century, macrophages are 
now understood to display a diverse range of functional niches and phenotypes that far extend 
beyond their role as phagocytes. In 1962, macrophage activation was first described in a paper6 
that observed how peritoneal macrophage antibacterial activity rapidly increased in response to 
listeria infection, allowing the cells to acquire resistance to the bacteria.  It was not until 1992 
that alternatively activated macrophages (AAM, or later, M2) were described in IL-4 stimulated 
murine macrophages, which displayed decreased secretion of pro-inflammatory cytokines and 
increased mannose receptor activity7. By 2001, the modern terminology for polarization states 
had entered the literature, with M1 and M2 replacing classical and alternative activation, 
respectively8.  
 Macrophages also play a crucial role in promoting the survival and proliferation of 
cancerous tumors. Tumor-associated macrophages (TAMs) are found in many solid tumors, and 
their density often correlates with disease severity and survival rates. These macrophages exhibit 
a chronic M2-like phenotype and secrete anti-inflammatory cytokines that attenuate healthy 
immune response in the tumor microenvironment9. Additionally, recent work has shown that 
TAMs are involved in the breakdown of the extracellular matrix (ECM) via uptake and 
degradation of collagen via cathepsins in lysosomes. This breakdown of the healthy ECM 
potentially promotes metastasis and growth, as cancerous tumors must break down healthy tissue 
in order to expand10.  
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 There have been many recent developments in refining the understanding of macrophage 
polarization from a binary dichotomy into a spectrum of different phenotypes. For instance, 
macrophage polarization dynamics are now known to differ between macrophage lineages. 
Macrophage lineages are often described by their cellular origin, such as monocyte-derived 
macrophages which arise from circulating monocytes within the bloodstream, or as tissue-
resident macrophages which arise from embryonic tissue1. Microglia have been found to exhibit 
more resistance to adopting an M2 phenotype than peripheral macrophages, which may help 
explain why many diseases of the CNS are characterized by chronic neuroinflammation. 
Additionally, recent work has shown that microglia exhibit different gene expression profiles in 
polarization than peripheral macrophages11. Different macrophage lineages/sub-populations are 
also known to show different levels of transcriptional and post-transcriptional regulation of 
polarization-associated genes12. Furthermore, through high-throughput sequencing platforms and 
systems biology techniques, macrophage polarization has been reassessed by some authors as a 
spectrum of phenotypes with complex characterization13.  
 Macrophage polarization is believed to play a key role in the pathophysiology of many 
diseases. Microglia, the tissue-resident macrophages of the central nervous system (CNS), are 
chronically-activated in Alzheimer’s disease, and the characteristic plaques of amyloid beta are 
known to synergistically induce M1 polarization in microglia in conjunction with pro-
inflammatory cytokines14. Additionally, mouse models of AD with the Nos2 gene knocked-out 
(which encodes iNOS, a canonical M1 marker protein) show significantly less cognitive 
decline14.  Traumatic brain injury (TBI) is also known to involve chronic microglial activation, 
and PET scan experiments have shown that microglial activation after an injury can persist for 
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over 17 years15. TBI is thought to be a risk factor for AD, and microglial activation may help to 
explain the interconnection between these two diseases.  
 Although there is extensive ongoing work into understanding the complete stratification 
of microglial activation states, there is a need for further investigation into time-domain 
computational modeling of macrophage polarization. These models can be employed to develop 
immunomodulatory strategies that target macrophage phenotypes without systemically 
disrupting immune response or inducing a pathological polarization response. My work has 
furnished a dataset suitable for training computational models that will model macrophage 
polarization as a control system.  By doing so, it may be possible to predict future macrophage 
polarization given a cytokine stimulation strategy, and determine what inputs are needed to shift 
polarization to a new setpoint. This form of modeling based on in vitro polarization responses 
has not been previously described in the literature. 
 
MATERIALS & METHODS: 
All cell culture experiments performed in this thesis were conducted using the RAW 
264.7 cell line, an adherent macrophage line which recapitulates polarization responses observed 
in primary cells. Using the RAW 264.7 (ATCC TIB-71™) macrophage cell line cultured from 
passages P5 to P10, we explored the dynamics of M1 polarization in response to temporal 
stimulation strategies using lipopolysaccharide (LPS, Sigma-Aldrich L2880), interferon-γ (IFN-
γ, R&D Systems 485-MI), and interleukin 4 (IL-4, PeproTech 214-14). LPS and IFN-γ were 
used to induce an M1 macrophage phenotype, as measured by increased expression of iNOS. 
Protein expression was measured using immunocytochemistry and Western blotting. 
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For immunocytochemistry experiments, cells were cultured in 96-well microwell plates 
until 70% confluence, and subsequently stimulated with LPS, IFN-γ, or IL-4 at given 
concentrations. Cells were fixed in 4% PFA, solubilized in 0.1% Triton-X, and stained with α-
iNOS (Cell Signaling Technology, Cat No. 13120, 1:400) and α-Arg1 (BD Bioscience, Cat No. 
610709, 1:400). iNOS expression was quantified by dividing total iNOS fluorescence by total 
cell count.  
For Western blotting experiments, cells were cultured in 6-well microwell plates and 
lysed in RIPA buffer (Boston BioProducts, BP-115), phenylmethylsulfonyl fluoride (PMSF, 
Sigma-Aldrich P7626-1G), and Mini-Complete Tablets (Sigma-Aldrich 11836153001). 
Membranes were probed for alpha-tubulin, iNOS, and Arginase-1. Membranes were imaged on 
an Odyssey CLx machine and analyzed in ImageStudio. These results were used to validate key 
findings in immunocytochemistry.  
To elucidate differences in polarization responses between 2D and 3D culture 
environments, a microfluidic platform developed by Dr. Levi B. Wood was employed to perform 
polarization experiments. Microfluidic devices were fabricated with polydimethylsiloxane 
(PDMS) on silicon microstructures and bound to glass coverslips. Microfluidic devices were 
treated with poly-D-lysine and filled with a 5 million cell per milliliter RAW 264.7 cell-









 The primary objective of this work was to produce an in vitro dataset to enable the 
computational modeling of macrophage polarization, with the goal of producing novel 
immunomodulatory strategies for chronic inflammatory diseases. These experiments investigated 
macrophage polarization responses to lipopolysaccharide (LPS), interferon-γ (IFN-γ), and 
interleukin-4, as measured by iNOS protein expression. While measuring iNOS does not capture 
the full spectrum of polarization responses, it is unique as a functional effector of polarization 
that is rapidly induced after stimulation. Because we have previously shown iNOS expression to 
peak after 24 hours post-stimulation, we have chosen a time sampling interval of 24 hours to 
measure M1 polarization after LPS stimulation17.  
 The results of re-stimulating RAW 264.7 macrophages with 1μg/mL LPS-conditioned 
medium by media replacement indicate that re-stimulation alone is insufficient for sustaining 
macrophage polarization beyond 24 hours. On the contrary, re-stimulation appeared to accelerate 
the decline in iNOS expression after 24 hours, with re-stimulated macrophages exhibiting lower 
iNOS expression at 48 hours than macrophages stimulated continuously for 48 hours without 
media replacement, as measured by immunocytochemistry (Figure 1). These effects were 




Figure 1. M1 polarization as measured by immunocytochemical staining for iNOS 
expression. Re-stimulation was performed using media replacement (n=3, mean±SEM). 
 
To determine whether re-stimulation with an orthogonal stimulus, such as interferon-γ, 
could sustain or increase iNOS expression beyond 24 hours, RAW 264.7s were cultured for 24 
hours in 1μg/mL LPS-conditioned media and re-stimulated with 100ng/mL IFN-γ conditioned 
media for an additional 24 hours. In contrast to the previous experiment, re-stimulation with an 
orthogonal stimulus resulted in markedly increased iNOS expression, as demonstrated in 





Figure 2. Representative immunocytochemistry images demonstrate that re-stimulation 
of LPS-treated macrophages with interferon gamma results in increased M1 polarization (n=3, 
representative images shown). 
 
While orthogonal stimulus successfully induced greater iNOS expression beyond 24 
hours, it was not known whether this effect persisted at a broader range of concentrations for 
LPS and IFN-γ. Subsequently, a range of concentrations for LPS (10ng/mL to 1μg/mL) and IFN-
γ (1ng/mL to 100ng/mL) were investigated, wherein RAW 264.7s were treated with either LPS 
or IFN-γ for 24 hours and subsequently re-stimulated with the opposite condition for an 
additional 24 hours. This experiment was performed to verify that the increase in iNOS 
expression observed in Figure 2 persisted at lower concentrations of LPS and IFN-γ. For each 
combination of conditions, iNOS expression was measured at the 48 hour endpoint by 
immunocytochemistry (Figure 3). When RAW 264.7s were first treated with LPS and re-
stimulated with IFN-γ, they exhibited further increases in iNOS expression which were dose-
dependent. However, RAW 264.7s treated first with IFN-γ and re-stimulated with LPS exhibited 




Figure 3.  iNOS expression after re-stimulation is dependent on the order of stimulation, 
as measured by immunocytochemistry (n=3, mean). 
 
It is known that there are differences in cell responses in three-dimensional culture 
environments, but it was not known whether the dynamics of macrophage polarization are 
significantly altered in 3D. To investigate whether dynamics observed in prior two-dimensional 
cell culture experiments exhibited the same patterns in iNOS expression in a three-dimensional 
environment, the LPS re-stimulation experiment described in Figure 1 was replicated using 
RAW 264.7s cultured within PDMS microfluidic devices. Microfluidic devices were seeded with 
a suspension of 5 million RAW 264.7s per milliliter in Matrigel and treated with LPS-
conditioned media for the indicated timepoints (Figure 4). Re-stimulation with LPS-conditioned 
media after 24 hours resulted in an accelerated decline in iNOS expression as observed in Figure 
1. However, unlike RAW 264.7s treated in microwell plates, peak iNOS expression in 





Figure 4. iNOS expression trajectory after LPS stimulation is extended in a microfluidic, 
three-dimensional culture platform (n=3, representative images shown) 
 
DISCUSSION: 
 I first sought to establish whether a stimulation scheme involving one pro-inflammatory 
stimulus, such as LPS, could sustain M1 polarization at a constant level for an extended period of 
time. Using various M1 stimulation strategies that incorporated re-stimulation (media 
replacement with fresh 1μg/mL LPS in cell-culture medium) strategies at a variety of different 
time points, I used immunocytochemistry to measure iNOS expression and quantified the degree 
of M1 polarization (Figure 1). Surprisingly, no single strategy maintained constant M1 
polarization, and media replacement appeared to accelerate the decline of M1 polarization. This 
was hypothesized to result from a loss of paracrine signaling, as M1 macrophages are known to 
secrete pro-inflammatory cytokines such as TNF-ɑ, which in turn promote greater M1 
polarization. Other inhibitory processes may also explain this effect, such as downregulation of 
the TLR4 receptor and loss of sensitivity to LPS, which must be explored in future work.  
  I next characterized whether re-stimulation with an orthogonal M1 stimulus, such as 
interferon-γ, is capable of sustaining M1 polarization and reaching a greater space of iNOS 
expression than one single stimulus alone. Interferon-γ is referred to as an orthogonal stimulus in 
this text as it activates genes required for M1 polarization via the JAK/STAT signaling pathway, 
while LPS drives TLR4 signaling. Because these pathways are largely separate, this was 
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hypothesized to increase the degree of M1 polarization in combination. I conditioned RAW 
264.7 macrophages with LPS and then re-stimulated with IFN-γ, which resulted in greater iNOS 
expression than any group that received LPS alone (Figure 2). This suggests that orthogonal 
stimulus can induce greater M1 polarization than any single stimulus alone. One possible 
explanation for this result is that negative feedback and inhibition processes that sufficiently 
limit response to LPS alone are overcome by orthogonal stimulation.  
 However, the prior experiment only measured M1 polarization in macrophages that were 
first treated with LPS and second with IFN-γ. It is possible that there are order-specific effects on 
M1 polarization when multiple cytokines or biomolecules are being used. Using four different 
concentrations of LPS and IFN-γ, I conditioned RAW 264.7 macrophages for 24 hours with 
either LPS or IFN-γ and then subsequently re-stimulated with the orthogonal stimulus for an 
additional 24 hours (Figure 3). In agreement with the previous experiment, combinations of 
stimuli resulted in far greater iNOS expression than a single stimulus alone. However, 
surprisingly there were order-specific effects, where IFN-γ followed by LPS appeared to reach a 
critical maximum at far lower concentrations. In contrast, LPS followed by IFN-γ followed a 
much more linear dose-dependent response. This suggests that models of macrophage 
polarization must account for information about prior stimuli before predicting responses to 
subsequent stimulation. 
 I also sought to show whether any differences exist between M1 polarization dynamics in 
a three-dimensional cell culture environment versus a two-dimensional culture. One of the major 
limitations of in vitro culture is that cells are suspended in a flat shape that fails to properly 
recapitulate the microenvironment of living tissue. Performing cell-culture experiments in a 
three-dimensional platform allows for studying cell responses in an environment which more 
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closely recapitulates the properties of native tissue and the extracellular matrix18. Previous 
investigators have demonstrated that the structural properties of an extracellular scaffold exert 
effects on macrophage polarization19. Thus, it was hypothesized that macrophages may exhibit 
altered dynamics when cultured in 3D or in the presence of an extracellular matrix. Using a 
PDMS microfluidic device with Matrigel as an extracellular protein scaffold, I conducted an 
experiment to investigate how LPS re-stimulation is altered in three-dimensional cultures (Figure 
4). Using the same stimulation schemes as described in Figure 1, I observed a similar response to 
re-stimulation where iNOS expression decreased at a greater rate than no re-stimulation at all. 
However, macrophages cultured in a three-dimensional environment also exhibited a more 
extended response to LPS, showing increases in iNOS past 24 hours and up to 48 hours, which is 
considerably longer than responses observed in two-dimensional microwell plates. These results 
present a novel effect of the culture environment on the dynamics of macrophage polarization 
and suggest that M1 polarization dynamics observed in vitro may exhibit a more delayed 
response in vivo under the same conditions. Further work may investigate whether injected 
macrophage cell lines exhibit different dynamics in a native murine tissue environment.  
 
CONCLUSION: 
 Macrophages are a crucial part of the immune system’s front line of defense, and their 
polarization states make them a versatile effector over the course of inflammatory responses. 
However, dysregulated dynamics of macrophage polarization are implicated in a number of 
pathologies such as Alzheimer’s disease and solid-tumor cancers. As a result, it is vital to 
understand the dynamics of how macrophages polarize in response to cytokines and 
biomolecules in order to correct for dysregulated polarization states in disease.  
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 Through this work, I have shown that M1 polarization is a refractory and transient 
process that cannot be sustained through one type of stimulus alone. In the case of LPS, iNOS 
expression begins to rapidly decline after 24 hours and is accelerated by replacement of media 
with fresh LPS. However, re-stimulation with a secondary orthogonal stimulus, such as IFN-γ, 
allows for greater iNOS expression and extended M1 responses. This response is order specific, 
and switching the stimulus type used in the first and second round of treatment has dramatic 
effects on the M1 polarization observed. Furthermore, three-dimensional culture environments 
show intriguing differences in M1 polarization responses versus two-dimensional environments, 
which may have implications for the process of translating the results macrophage polarization 
responses into therapeutic interventions for live organisms. For instance, the delayed 
macrophage response to LPS in 3D culture indicates that successful inhibition of inflammation in 
vivo may require more prolonged delivery of inhibitory inputs (i.e. M2 cytokines, receptor 
inhibitors) than what is sufficient for experiments performed in 2D culture environments.  
 These results expand our understanding of how macrophages transduce signals from their 
environment into a rich spectrum of polarization responses with complicated dynamics. These 
results can form the basis for future models that may allow us to develop new 
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